Elekta

This week, we had the honor of accompanying Datuk Seri Zambry Abd Kadir, the Malaysian Minister of Higher Education, on a visit to Institut Perubatan dan Pergigian Termaju, Universiti Sains Malaysia where he learned about their radiotherapy services. During the visit, Elekta's Head of Marketing for Asia Pacific & Japan, Yohei Watanabe, recognized the hospital as a leading BrachyAcademy site and Paul Lee, Head of the Brachytherapy Business Line for Asia Pacific & Japan, presented a research grant to explore the potential of oral tongue brachytherapy. We'd like to thank Dr. Yusri Musa, Lecturer and Otorhinolaryngologist/Head & Neck Cancer Specialist and Assoc. Prof. Gokula Appalanaido, Head of Radiation Oncology, for the visit and their clinical partnership.

To encourage work-life harmony and well-being among employees, Elekta kicked off a company-wide initiative, the Pink Ribbon Challenge, in January. Supporting the Elekta Foundation, the challenge has had employees lacing up their running shoes and embracing the spirit of camaraderie all over the globe. Here’s a glimpse at some of the fun we’ve had clocking up miles and kilometers, all leading up to the race in September. #LifeatElekta

A standard of care for treating distal rectal cancer is chemoradiation followed by surgical removal of the tumor, which may result in patients requiring a colostomy.  #radonc

For MR-Linac users who plan to treat pancreatic tumors, MR-guided SBRT has been established as a novel and promising therapy – with early outcomes demonstrating prescribed doses up to 50 Gy in five fractions can safely be delivered while maintaining low acute toxicity rates. Read more in this research article ➡️ https://bit.ly/3VKFAht #MRgRT

This week, our President and CEO, Gustaf Salford, was part of a Swedish delegation that made a visit to Kyiv to discuss how strengthening business and trade ties could bolster Ukrainian society. During the visit, Gustaf presented to President Volodymyr Zelenskyy and other government officials about how the 15 recently-ordered Elekta Harmony linacs will help improve radiotherapy access for the almost one million people living with cancer in the country.

This week, the Swedish Minister of Health Acko Ankarberg Johansson visited the Maria Sklodowska-Curie National Research Institute of Oncology. During the visit, they shared their vision for the future of cancer care in the region, as well as how they use Elekta's radiotherapy solutions to improve quality of life for pediatric cancer patients. We are proud to work with experts in the field, such as professors Beata Jagelska, Andrzej Kawecki and Lucjan Wyricz and their teams dedicated to provide best quality care to children with cancer.  

Seeking to achieve data security and cost predictability, Centre de Haute Energie (CHE Nice), was the first in France to move to Elekta Axis Cloud. “The cloud is the solution,” says Prof. René-Jean Bensadoun, Chairman of CHE. "It brings all our machines and software together, protecting our data and system performance. Everyone in our department is aware of the benefits of this evolution to the cloud.” Read why they see the cloud as essential to the future of oncology care ➡️ https://bit.ly/3xv2TTn. #HealthIT #oncology #radiotherapy

With MR-guided radiation therapy (MRgRT) you can adapt and optimize the radiation treatment plan on a daily basis. Clinical experience shows why this matters—with tighter margins and normal tissue sparing toxicity is reduced, resulting in an improved quality of life for patients. Learn more about how Elekta Unity MR-Linac is advancing prostate treatments ➡️ https://bit.ly/4ch7gAI

We value the many women engineers who innovate at Elekta. To mark #INWED24, we invite you to read about six of these individuals, what inspires them and how they're using their talents to help caregivers and patients. https://bit.ly/42U9ZKH #EnhancedByEngineering #LifeatElekta

In radiotherapy, a multileaf collimator (or MLC) is used to shape the beam generated by a Linac. While this might sound complex, this interactive model designed by our Elekta UK Engineering team helps those unfamiliar with radiation therapy to understand how it can precisely target cancer cells.   Massive thank you to John Allen for taking the time to explain how this works.